1-7 of 7
Marco Foppoli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Andres JM Ferreri, MD, Teresa Calimeri, MD PhD, Paolo Lopedote, MD, Ilaria Francaviglia, Rita Daverio, MD, Chiara Iacona, Cristina Belloni, BD, Sara Steffanoni, MD, Elena Anghileri, MD, Angelo Diffidenti, Annamaria Finardi, BD, Filipppo Gagliardi, MD, Nicoletta Anzalone, MD, Alessandro Nonis, Roberto Furlan, MD, Piera Angelillo, MD, Marianna Sassone, MD, Daniela De Lorenzo, BD, Maria Rosa Terreni, MD, Marco Foppoli, Elena Guggiari, MD, Vittoria Tarantino, MD, Marika Eoli, MD, Fabio Ciceri, MD, Claudio Doglioni, Massimo Locatelli, MD, Maurilio Ponzoni, MD, Maria Giulia Cangi
Journal: Blood
Blood (2019) 134 (Supplement_1): 4114.
https://doi.org/10.1182/blood-2019-128298
Published: 2019
Journal Articles

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

Clinical Trials & Observations
Andrés J. M. Ferreri, Teresa Calimeri, Gian Marco Conte, Dario Cattaneo, Federico Fallanca, Maurilio Ponzoni, Eloise Scarano, Flavio Curnis, Alessandro Nonis, Paolo Lopedote, Giovanni Citterio, Letterio S. Politi, Marco Foppoli, Stefania Girlanda, Marianna Sassone, Salvatore Perrone, Caterina Cecchetti, Fabio Ciceri, Claudio Bordignon, Angelo Corti, Nicoletta Anzalone
Journal: Blood
Blood (2019) 134 (3): 252–262.
https://doi.org/10.1182/blood.2019000633
Published: 2019
Includes: Supplemental data
Journal Articles

High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial

Andrés J.M. Ferreri, Giovanni Donadoni, MD, Maria Giuseppina Cabras, MD, Caterina Patti, MD, Michael Mian, Renato Zambello, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Alfonso D'Arco, Gianluca Doa, Marta Bruno-Ventre, Marco Foppoli, MD, Alessandro Fanni, MD, Antonino Mulè, MD, Fabio Ciceri, MD, Federico Caligaris-Cappio, MD
Journal: Blood
Blood (2014) 124 (21): 1724.
https://doi.org/10.1182/blood.V124.21.1724.1724
Published: 2014
Journal Articles

Risk-Tailored CNS Prophylaxis In 194 Patients With Diffuse Large B-CELL Lymphoma (DLBCL) Treated In The Rituximab ERA: Risk Definition By Clinical Variables and Ontogenic Stratification

Marta Bruno Ventre, MD, Marco Foppoli, MD, Giovanni Citterio, MD, Giovanni Donadoni, MD, Maurilio Ponzoni, MD, Silvia Govi, MD, Lydia Scarfò, MD, Marianna Sassone, MD, Federico Caligaris -Cappio, MD, Prof., Andres J.M. Ferreri, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4365.
https://doi.org/10.1182/blood.V122.21.4365.4365
Published: 2013
Journal Articles

Clinical Relevance of the Dose of Cytarabine In the Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Chemotherapy Combination

Andrés JM Ferreri, MD, Giada Licata, Marco Foppoli, Gaetano Corazzelli, Emanuele Zucca, Caterina Stelitano, Francesco Zaja, Sergio Fava, Rossella Paolini, Alberto Franzin, Letterio Politi, Maurilio Ponzoni, MD, Michele Reni
Journal: Blood
Blood (2010) 116 (21): 1780.
https://doi.org/10.1182/blood.V116.21.1780.1780
Published: 2010
Journal Articles

Post-Chemotherapy Brain Irradiation in Primary CNS Lymphomas: Impact on Survival of Different Fields and Doses.

Andres JM Ferreri, Chiara Verona, Letterio Salvatore Politi, Lucia Perna, Anna Chiara, Marco Foppoli, Giada Licata, Silvia Mappa, Fabio Ciceri, Piero Picozzi, Alberto Franzin, Silvia Govi, Maurilio Ponzoni, MD, Maria Rosa Terreni, Eugenio Villa, Michele Reni, M.D.
Journal: Blood
Blood (2009) 114 (22): 2696.
https://doi.org/10.1182/blood.V114.22.2696.2696
Published: 2009
Journal Articles

Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Andres JM Ferreri, MD, Michele Reni, M.D., Marco Foppoli, M.D., Maurizio Martelli, M.D., Marina Siakantaris, M.D., Maurizio Frezzato, M.D., Maria Giuseppina Cabras, M.D., Alberto Fabbri, M.D., Gaetano Corazzelli, M.D., Fiorella Ilariucci, M.D., Giuseppe Rossi, M.D., Riccardo Soffietti, M.D., Caterina Stelitano, M.D., Daniele Vallisa, M.D., Francesco Zaja, M.D., Marta Gelemur, M.D., Gian Marco Aondio, M.D., Giuseppe Avvisati, M.D., Monica Balzarotti, MD, Alba Brandes, M.D., Maria Joao Costa, MD, Henry Gomez, M.D., Attilio Guarini, M.D., Graziella Pinotti, M.D., Luigi Rigacci, M.D., Catrina Uhlmann, M.D., Maria Angelopoulou, M.D., Maria Tirindelli, M.D., Virginia Naso, M.D., Alberto Franzin, M.D., Nicoletta Anzalone, M.D., Maurilio Ponzoni, M.D., Emanuele Zucca, M.D., Federico Caligaris- Cappio, M.D., Franco Cavalli, M.D.
Journal: Blood
Blood (2008) 112 (11): 580.
https://doi.org/10.1182/blood.V112.11.580.580
Published: 2008